Epithelial-mesenchymal transitions in development and disease, Cell, vol.139, issue.5, pp.871-890, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02912716
Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study, Appl. Immunohistochem. Mol. Morphol, vol.18, issue.5, pp.433-441, 2010. ,
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells, J. Clin. Invest, vol.122, issue.5, pp.1849-1868, 2012. ,
,
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition, Science, vol.339, pp.580-584, 2013. ,
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal, J. Cell. Mol. Med, vol.15, issue.5, pp.1066-1070, 2011. ,
Classification of circulating tumor cells by epithelial-mesenchymal transition markers, PLoS One, vol.10, issue.4, p.123976, 2015. ,
The detection of EpCAM(+) and EpCAM(?) circulating tumor cells, Sci. Rep, vol.5, p.12270, 2015. ,
Molecular biomarker analyses using circulating tumor cells, PLoS One, vol.5, issue.9, p.12517, 2010. ,
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis, Cancer Res, vol.73, issue.7, pp.2059-2069, 2013. ,
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis, Cancer Cell, vol.22, issue.6, pp.725-736, 2012. ,
To differentiate or not-routes towards metastasis, Nat. Rev. Cancer, vol.12, issue.6, pp.425-436, 2012. ,
EMT and dissemination precede pancreatic tumor formation, Cell, vol.148, issue.1-2, pp.349-361, 2012. ,
Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact, Cancer Treat Rev, vol.38, issue.6, pp.689-697, 2012. ,
Emerging evidence of epithelial-tomesenchymal transition in lung carcinogenesis, Respirology, vol.17, issue.7, pp.1048-1059, 2012. ,
Epithelial-mesenchymal transition in ovarian cancer, Cancer Lett, vol.291, issue.1, pp.59-66, 2010. ,
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?, Nat. Rev. Urol, vol.8, issue.8, pp.428-439, 2011. ,
Therapeutic and prognostic importance of epithelialmesenchymal transition in liver cancers: insights from experimental models, Crit. Rev. Oncol. Hematol, vol.83, issue.3, pp.319-328, 2012. ,
Protein kinase C a is a central signaling node and therapeutic target for breast cancer stem cells, Cancer Cell, vol.24, issue.3, pp.347-364, 2013. ,
MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progressiono, Biol. Cell, vol.104, issue.1, pp.3-12, 2012. ,
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, Genes Dev, vol.22, issue.7, pp.894-907, 2008. ,
Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression, Neoplasia, vol.15, issue.2, pp.180-191, 2013. ,
microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition, Oncol. Lett, vol.7, issue.4, pp.1233-1238, 2014. ,
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition, Nat. Commun, vol.7, issue.5, p.2977, 2014. ,
MicroRNA-374a activates Wnt/b-catenin signaling to promote breast cancer metastasis, J. Clin. Invest, vol.123, issue.2, pp.566-579, 2013. ,
Epithelial-mesenchymal transition in tumor microenvironment, Cell Biosci, vol.1, issue.1, p.29, 2011. ,
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis, Nat. Commun, vol.4, p.1795, 2013. ,
The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis, Nat. Cell Biol, vol.15, issue.6, pp.677-687, 2013. ,
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis, Cancer Cell, vol.20, issue.5, pp.576-590, 2011. ,
Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility, Nat. Cell Biol, vol.11, issue.11, pp.1287-1296, 2009. ,
Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-b, Sci. Signal, vol.7, p.5, 2014. ,
Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition, Int. J. Oncol, vol.42, issue.2, pp.556-564, 2013. ,
Moses, ation of the Erk pathway is required for TGF-beta1-induced EMT in vitro, Neoplasia, vol.6, pp.603-610, 2004. ,
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells, Cancer Lett, vol.310, issue.1, pp.1-8, 2011. ,
TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells, Cancer Res, vol.72, pp.6382-6392, 2012. ,
Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelialmesenchymal transition, Nat. Cell Biol, vol.6, issue.10, pp.931-940, 2004. ,
MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells, Sci. Signal, vol.2, p.62, 2009. ,
The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines, Cancer Res, vol.63, issue.9, pp.2172-2178, 2003. ,
Activation of PI3 kinase/Akt/HIF-1a pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma, Int. J. Oncol, vol.40, issue.2, pp.461-468, 2012. ,
PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage, Oncogene, vol.29, pp.3554-3565, 2010. ,
Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition, Oncogene, vol.26, issue.53, pp.7445-7456, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00235814
Wnt-dependent regulation of the E-cadherin repressor snail, J. Biol. Chem, vol.280, pp.11740-11748, 2005. ,
Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast cancer 1, early onset (BRCA1) repression, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.16654-16659, 2012. ,
Diverse targets of b-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse, Cancer Res, vol.75, issue.16, pp.3398-3410, 2015. ,
Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors, J. Immunol, vol.187, issue.1, pp.27-36, 2011. ,
Immune suppression and resistance mediated by constitutive activation of Wnt/b-catenin signaling in human melanoma cells, J. Immunol, vol.189, issue.5, pp.2110-2117, 2012. ,
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition, Oncoimmunology, vol.1, issue.5, pp.649-658, 2012. ,
Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition, Oncoimmunology, vol.2, issue.9, p.25820, 2013. ,
Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections, J. Proteome Res, vol.6, issue.4, pp.1295-1305, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00167250
The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumorrelapse biomarker: evidence from mass spectrometry profiling, Histochem. Cell Biol, vol.138, issue.1, pp.141-154, 2012. ,
Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancerassociated stroma, J. Proteome Res, vol.13, issue.11, pp.4730-4738, 2014. ,
TGF-b and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells, Mol. Immunol, vol.65, issue.1, pp.34-42, 2015. ,
Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ, vol.18, pp.1470-1477, 2011. ,
Outgrowth of single oncogene-expressing cells from suppressive epithelial environments, Nature, vol.482, pp.410-413, 2012. ,
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?, Oncogene, vol.27, pp.6920-6929, 2008. ,
Reis-Filho, b-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation, Mod. Pathol, vol.24, issue.2, pp.209-231, 2011. ,
Clinical significance of E-cadherin, b-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma, J. Clin. Pathol, vol.66, issue.11, pp.937-945, 2013. ,
Clinical significance of altered expression of b-catenin and Ecadherin in oral dysplasia and cancer: potential link with ALCAM expression, PLoS One, vol.8, issue.6, p.67361, 2013. ,
The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis, Dis. Esophagus, vol.27, issue.1, pp.79-86, 2014. ,
Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma, J. Surg. Oncol, vol.106, issue.3, pp.304-310, 2012. ,
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis, Cell Res, vol.21, issue.2, pp.275-289, 2011. ,
Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition, Cancer Res, vol.66, pp.9543-9556, 2006. ,
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence, Mol. Cancer Res, vol.9, pp.1644-1657, 2011. ,
Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer, Clin. Exp. Metastasis, vol.28, issue.8, pp.811-818, 2011. ,
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma, Cancer Cell, vol.24, issue.4, pp.466-480, 2013. ,
High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma, Ann. Surg. Oncol, vol.19, issue.9, pp.2971-2979, 2012. ,
Nuclear expression of snail is an independent negative prognostic factor in human breast cancer, Dis. Markers, vol.35, issue.5, pp.337-344, 2013. ,
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression, BMC Cancer, vol.11, p.350, 2011. ,
Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas, Oncotarget, vol.2, pp.1165-1175, 2011. ,
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target, Cancer, 2013. ,
TWIST1 is expressed in colorectal carcinomas and predicts patient survival, PLoS One, vol.6, issue.3, p.18023, 2011. ,
Twist-1 up-regulation in carcinoma correlates to poor survival, Int. J. Mol. Sci, vol.15, pp.21621-21630, 2014. ,
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression, BMC Cancer, vol.11, p.350, 2011. ,
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nat. Rev. Cancer, vol.4, issue.2, pp.118-132, 2004. ,
N-cadherin/FGFR promotes metastasis through epithelial-tomesenchymal transition and stem/progenitor cell-like properties, Oncogene, vol.33, pp.3411-3421, 2014. ,
Prognostic significance of twist and N-cadherin expression in NSCLC, PLoS One, vol.8, issue.4, p.62171, 2013. ,
N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors, Clin. Cancer Res, vol.12, issue.9, pp.2780-2787, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00484920
Prognostic significance of N-cadherin expression in oral squamous cell carcinoma, Anticancer Res, vol.31, pp.4211-4218, 2011. ,
Proteomic map of peripheral blood mononuclear cells, Proteomics, vol.8, issue.10, pp.2045-2051, 2008. ,
Overexpression of vimentin: role in the invasive phenotype in an androgenindependent model of prostate cancer, Cancer Res, vol.63, issue.9, pp.2306-2311, 2003. ,
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion, Proc. Natl. Acad. Sci. U. S. A, vol.104, issue.8, pp.2803-2808, 2007. ,
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma, Proteomics, vol.6, issue.9, pp.2853-2864, 2006. ,
Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression, Proteomics, vol.7, issue.12, pp.1973-1983, 2007. ,
MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers, Med. Sci. Monit, vol.16, issue.8, pp.233-278, 2010. ,
Vimentin expression is associated with decreased survival in gastric cancer, Oncol. Rep, vol.25, issue.5, pp.1235-1242, 2011. ,
Vimentin in cancer and its potential as a molecular target for cancer therapy, Cell. Mol. Life Sci, vol.68, issue.18, pp.3033-3046, 2011. ,
Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome, Mod. Pathol, vol.23, issue.2, pp.213-224, 2010. ,
Vimentin as a poor prognostic factor for triple-negative breast cancer, J. Cancer Res. Clin. Oncol, vol.139, issue.5, pp.739-746, 2013. ,
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basallike breast cancers: association with an aggressive tumour phenotype, Breast Cancer Res. Treat, vol.138, issue.1, pp.81-90, 2013. ,
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second-or third-line therapy, Anticancer Res, vol.32, issue.2, pp.537-552, 2012. ,
Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma, Br. J. Cancer, vol.44, issue.4, pp.502-505, 1981. ,
,
MicroRNA122 is a key regulator of a-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma, Nat. Commun, vol.2, p.338, 2011. ,
MicroRNA-plays a critical role in liver homeostasis and hepatocarcinogenesis, J. Clin. Invest, vol.122, issue.8, pp.2884-2897, 2012. ,
Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (< or = 2 cm), J. Proteome Res, vol.9, issue.4, pp.1923-1930, 2010. ,
Mucins in cancer: function, prognosis and therapy, Nat. Rev. Cancer, vol.9, pp.874-885, 2009. ,
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N. Engl. J. Med, vol.309, pp.883-887, 1983. ,
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma, Gynecol. Oncol, vol.30, issue.1, pp.7-14, 1988. ,
MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis6 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis, Gynecol. Oncol, vol.121, issue.3, pp.434-443, 2011. ,
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome, Clin. Cancer Res, vol.14, issue.16, pp.5198-5208, 2008. ,
Analysis of mucins: role in laboratory diagnosis, J. Clin. Pathol, vol.1, issue.9, pp.1018-1024, 2008. ,
Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma, Tumour Biol, vol.35, issue.9, pp.9101-9109, 2014. ,
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition, Oncogene, vol.30, pp.1449-1459, 2011. ,
MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition, Oncogene, vol.33, pp.1680-1689, 2014. ,
Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and adsorption techniques, J. Exp. Med, vol.121, issue.1, pp.439-462, 1965. ,
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis, Cancer Metastasis Rev, vol.32, pp.643-671, 2013. ,
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues, Semin. Cancer Biol, vol.9, issue.2, pp.67-81, 1999. ,
CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer, Int. J. Oncol, vol.43, issue.3, pp.877-885, 2013. ,
Expression of cell adhesion molecules and prognosis in breast cancer, Br. J. Surg, vol.100, issue.2, pp.252-260, 2013. ,
Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid, J. Proteome Res, vol.11, issue.10, pp.5034-5045, 2012. ,
Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition, J. Proteome Res, vol.8, issue.6, pp.2827-2837, 2009. ,
Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients, Mol. Cancer, vol.14, issue.1, p.107, 2015. ,
A systems view of epithelialmesenchymal transition signaling states, Clin. Exp. Metastasis, vol.28, issue.2, pp.137-155, 2011. ,
HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways, J. Proteome Res, vol.13, issue.6, pp.2874-2886, 2014. ,
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, 2015. ,
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, 2015. ,
Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines, Mol. Cells, vol.37, pp.888-898, 2014. ,
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response, Int. J. Proteomics, p.896476, 2011. ,
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature, Mol. Biosyst, vol.9, issue.6, pp.1127-1138, 2013. ,
,
, kConFab/AOCS Investigators
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis, BMC Med, vol.13, p.156, 2015. ,
The proteomic landscape of triple-negative breast cancer, Cell Rep, vol.11, issue.4, pp.630-644, 2015. ,
Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells, J. Biotechnol, vol.202, pp.3-11, 2015. ,
Zaidel-Bar, E-cadherin interactome complexity and robustness resolved by quantitative proteomics, Sci. Signal, vol.7, p.7, 2014. ,
Epithelialmesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients, EMBO Mol. Med, vol.6, issue.10, pp.1279-1293, 2014. ,
A Combined shotgun and targeted mass spectrometry strategy for breast cancer biomarker discovery, J. Proteome Res, vol.14, issue.7, pp.2807-2818, 2015. ,
Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring, Expert Rev. Proteomics, vol.10, issue.6, pp.551-566, 2013. ,
Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues, Mol. Cell. Proteomics, vol.14, issue.5, pp.1400-1410, 2015. ,